Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Apatinib with or without Capecitabine in Advanced Gastric Cancer
NCT03598348Phase 3Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Rivoceranib in gastric cancer (GC), sponsored by Huazhong University of Science and Technology. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03598348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598348.